NRx Historical Financial Ratios

NRXPW Stock

USD 0.07 0.00 0.000004%

NRx Pharmaceuticals is lately reporting on over 87 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0 will help investors to properly organize and evaluate NRx Pharmaceuticals financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRx Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

About NRx Financial Ratios Analysis

NRx PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate NRx Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on NRx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across NRx Pharmaceuticals history.

NRx Pharmaceuticals Financial Ratios Chart

At this time, NRx Pharmaceuticals' Days Payables Outstanding is fairly stable compared to the past year. Income Quality is likely to climb to 0.44 in 2025, despite the fact that Book Value Per Share is likely to grow to (2.10).

Average Payables Payables Turnover Cash Per Share Days Payables Outstanding Debt To Assets

Add Fundamental

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Most ratios from NRx Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into NRx Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRx Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.At this time, NRx Pharmaceuticals' Days Payables Outstanding is fairly stable compared to the past year. Income Quality is likely to climb to 0.44 in 2025, despite the fact that Book Value Per Share is likely to grow to (2.10).

NRx Pharmaceuticals fundamentals Correlations

	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield
Ptb Ratio		0.01	-0.01	-0.16	0.01	-0.06	1.0	-0.16	-0.28	-0.43	-0.1	-0.42	-0.07	0.0	0.86	-0.38	0.62	0.86	0.45	0.06	-0.57	0.86	0.22	0.21	0.86	0.0
Book Value Per Share	0.01		0.65	0.55	0.47	0.81	0.01	0.55	-0.18	0.86	0.73	0.86	0.95	1.0	0.03	0.13	0.63	0.03	-0.86	-0.06	0.14	0.04	-0.34	0.86	0.03	0.64
Free Cash Flow Yield	-0.01	0.65		0.78	0.62	0.95	-0.01	0.78	-0.71	0.74	0.93	0.75	0.61	0.64	-0.34	-0.3	0.06	-0.34	-0.72	-0.06	-0.5	-0.34	-0.31	0.81	-0.34	0.96
Operating Cash Flow Per Share	-0.16	0.55	0.78		0.22	0.69	-0.16	1.0	-0.71	0.62	0.72	0.61	0.66	0.53	-0.43	-0.07	-0.01	-0.43	-0.62	0.17	-0.31	-0.43	-0.49	0.48	-0.43	0.64
Average Payables	0.01	0.47	0.62	0.22		0.7	0.01	0.22	-0.05	0.53	0.49	0.57	0.44	0.46	-0.24	-0.25	0.03	-0.24	-0.5	-0.03	-0.29	-0.24	-0.22	0.76	-0.24	0.79
Capex To Depreciation	-0.06	0.81	0.95	0.69	0.7		-0.06	0.69	-0.52	0.86	0.9	0.88	0.75	0.8	-0.29	-0.26	0.22	-0.29	-0.84	-0.09	-0.27	-0.28	-0.34	0.9	-0.28	0.95
Pb Ratio	1.0	0.01	-0.01	-0.16	0.01	-0.06		-0.16	-0.28	-0.43	-0.1	-0.42	-0.07	0.0	0.86	-0.38	0.62	0.86	0.45	0.06	-0.57	0.86	0.22	0.21	0.86	0.0
Free Cash Flow Per Share	-0.16	0.55	0.78	1.0	0.22	0.69	-0.16		-0.71	0.62	0.72	0.61	0.66	0.53	-0.43	-0.07	-0.01	-0.43	-0.62	0.17	-0.31	-0.43	-0.49	0.48	-0.43	0.64
Roic	-0.28	-0.18	-0.71	-0.71	-0.05	-0.52	-0.28	-0.71		-0.19	-0.63	-0.18	-0.16	-0.17	0.07	0.47	0.01	0.07	0.19	0.03	0.73	0.07	0.08	-0.31	0.07	-0.53
Inventory Turnover	-0.43	0.86	0.74	0.62	0.53	0.86	-0.43	0.62	-0.19		0.82	1.0	0.82	0.87	-0.44	0.16	0.18	-0.44	-1.0	-0.11	0.2	-0.44	-0.4	0.75	-0.44	0.74
Net Income Per Share	-0.1	0.73	0.93	0.72	0.49	0.9	-0.1	0.72	-0.63	0.82		0.83	0.63	0.73	-0.27	-0.01	0.16	-0.27	-0.82	-0.16	-0.32	-0.27	-0.25	0.79	-0.27	0.86
Days Of Inventory On Hand	-0.42	0.86	0.75	0.61	0.57	0.88	-0.42	0.61	-0.18	1.0	0.83		0.82	0.86	-0.44	0.13	0.17	-0.44	-0.99	-0.1	0.17	-0.44	-0.4	0.77	-0.44	0.76
Payables Turnover	-0.07	0.95	0.61	0.66	0.44	0.75	-0.07	0.66	-0.16	0.82	0.63	0.82		0.94	-0.09	0.13	0.52	-0.09	-0.82	0.03	0.15	-0.09	-0.43	0.77	-0.09	0.6
Cash Per Share	0.0	1.0	0.64	0.53	0.46	0.8	0.0	0.53	-0.17	0.87	0.73	0.86	0.94		0.04	0.14	0.63	0.04	-0.87	-0.08	0.15	0.04	-0.33	0.85	0.04	0.63
Pocfratio	0.86	0.03	-0.34	-0.43	-0.24	-0.29	0.86	-0.43	0.07	-0.44	-0.27	-0.44	-0.09	0.04		-0.06	0.78	1.0	0.44	-0.1	-0.11	1.0	0.38	0.04	1.0	-0.33
Interest Coverage	-0.38	0.13	-0.3	-0.07	-0.25	-0.26	-0.38	-0.07	0.47	0.16	-0.01	0.13	0.13	0.14	-0.06		0.06	-0.06	-0.18	0.01	0.51	-0.06	-0.06	-0.13	-0.06	-0.31
Capex To Operating Cash Flow	0.62	0.63	0.06	-0.01	0.03	0.22	0.62	-0.01	0.01	0.18	0.16	0.17	0.52	0.63	0.78	0.06		0.78	-0.18	-0.02	0.11	0.78	-0.01	0.48	0.78	0.05
Pfcf Ratio	0.86	0.03	-0.34	-0.43	-0.24	-0.29	0.86	-0.43	0.07	-0.44	-0.27	-0.44	-0.09	0.04	1.0	-0.06	0.78		0.44	-0.1	-0.11	1.0	0.38	0.04	1.0	-0.33
Days Payables Outstanding	0.45	-0.86	-0.72	-0.62	-0.5	-0.84	0.45	-0.62	0.19	-1.0	-0.82	-0.99	-0.82	-0.87	0.44	-0.18	-0.18	0.44		0.11	-0.22	0.44	0.4	-0.72	0.44	-0.71
Income Quality	0.06	-0.06	-0.06	0.17	-0.03	-0.09	0.06	0.17	0.03	-0.11	-0.16	-0.1	0.03	-0.08	-0.1	0.01	-0.02	-0.1	0.11		-0.05	-0.1	-0.86	-0.06	-0.1	-0.06
Roe	-0.57	0.14	-0.5	-0.31	-0.29	-0.27	-0.57	-0.31	0.73	0.2	-0.32	0.17	0.15	0.15	-0.11	0.51	0.11	-0.11	-0.22	-0.05		-0.11	-0.07	-0.28	-0.11	-0.47
Ev To Operating Cash Flow	0.86	0.04	-0.34	-0.43	-0.24	-0.28	0.86	-0.43	0.07	-0.44	-0.27	-0.44	-0.09	0.04	1.0	-0.06	0.78	1.0	0.44	-0.1	-0.11		0.38	0.04	1.0	-0.33
Pe Ratio	0.22	-0.34	-0.31	-0.49	-0.22	-0.34	0.22	-0.49	0.08	-0.4	-0.25	-0.4	-0.43	-0.33	0.38	-0.06	-0.01	0.38	0.4	-0.86	-0.07	0.38		-0.28	0.38	-0.3
Return On Tangible Assets	0.21	0.86	0.81	0.48	0.76	0.9	0.21	0.48	-0.31	0.75	0.79	0.77	0.77	0.85	0.04	-0.13	0.48	0.04	-0.72	-0.06	-0.28	0.04	-0.28		0.04	0.88
Ev To Free Cash Flow	0.86	0.03	-0.34	-0.43	-0.24	-0.28	0.86	-0.43	0.07	-0.44	-0.27	-0.44	-0.09	0.04	1.0	-0.06	0.78	1.0	0.44	-0.1	-0.11	1.0	0.38	0.04		-0.33
Earnings Yield	0.0	0.64	0.96	0.64	0.79	0.95	0.0	0.64	-0.53	0.74	0.86	0.76	0.6	0.63	-0.33	-0.31	0.05	-0.33	-0.71	-0.06	-0.47	-0.33	-0.3	0.88	-0.33

Click cells to compare fundamentals

NRx Pharmaceuticals Account Relationship Matchups

NRx Pharmaceuticals fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Ptb Ratio	(191.04)	107.79	98.53	(2.97)	(1.0)	(0.95)
Book Value Per Share	(1.28)	0.44	0.11	(1.55)	(2.21)	(2.1)
Free Cash Flow Yield	(2.71E-4)	(0.0168)	(0.0545)	(0.62)	(0.46)	(0.44)
Operating Cash Flow Per Share	(0.0661)	(0.8)	(0.6)	(2.86)	(1.01)	(1.06)
Pb Ratio	(191.04)	107.79	98.53	(2.97)	(1.0)	(0.95)
Free Cash Flow Per Share	(0.0661)	(0.8)	(0.6)	(2.86)	(1.01)	(1.06)
Roic	0.29	(4.18)	(2.32)	10.72	1.11	0.64
Net Income Per Share	(0.36)	(1.53)	(0.54)	(3.98)	(2.39)	(2.27)
Cash Per Share	0.23	0.59	0.3	0.61	0.14	0.13
Pocfratio	(3.7K)	(59.48)	(18.36)	(1.61)	(2.18)	(2.28)
Capex To Operating Cash Flow	(8.83E-4)	(1.86E-4)	(2.52E-4)	(1.39E-4)	(1.25E-4)	(1.31E-4)
Pfcf Ratio	(3.7K)	(59.47)	(18.36)	(1.61)	(2.18)	(2.28)
Income Quality	0.0437	0.41	1.0	0.72	0.42	0.44
Roe	0.28	(3.45)	(4.76)	2.57	1.08	1.14
Ev To Operating Cash Flow	(3.7K)	(58.76)	(18.12)	(1.82)	(2.66)	(2.79)
Pe Ratio	(677.26)	(31.27)	(20.72)	(1.16)	(0.92)	(0.97)
Return On Tangible Assets	(4.2)	(2.19)	(1.36)	(4.12)	(6.88)	(6.54)
Ev To Free Cash Flow	(3.7K)	(58.75)	(18.12)	(1.82)	(2.66)	(2.79)
Earnings Yield	(0.001477)	(0.032)	(0.0483)	(0.87)	(1.09)	(1.03)
Net Debt To E B I T D A	0.0205	0.29	0.24	(0.15)	(0.28)	(0.26)
Current Ratio	0.0635	2.74	1.56	0.36	0.15	0.14
Tangible Book Value Per Share	(1.28)	0.44	0.11	(1.55)	(2.21)	(2.1)
Shareholders Equity Per Share	(1.28)	0.44	0.11	(1.55)	(2.21)	(2.1)
Debt To Equity	(0.0182)	0.0249	1.42	(0.78)	(0.28)	(0.27)
Capex Per Share	5.8E-5	1.49E-4	1.52E-4	3.96E-4	3.56E-4	3.74E-4
Graham Net Net	(1.11)	0.33	0.025	(1.91)	(2.42)	(2.3)
Interest Debt Per Share	0.0249	0.0114	0.16	1.23	0.65	1.05
Debt To Assets	0.27	0.0158	0.41	1.25	1.8	1.89
Enterprise Value Over E B I T D A	(161.66)	(23.81)	(18.13)	(1.31)	(1.53)	(1.45)
Price Earnings Ratio	(677.26)	(31.27)	(20.72)	(1.16)	(0.92)	(0.97)
Price Book Value Ratio	(191.04)	107.79	98.53	(2.97)	(1.0)	(0.95)
Price Earnings To Growth Ratio	4.67	(0.0962)	0.32	(0.001814)	0.0231	0.0242
Price To Operating Cash Flows Ratio	(3.7K)	(59.48)	(18.36)	(1.61)	(2.18)	(2.28)
Price To Free Cash Flows Ratio	(3.7K)	(59.47)	(18.36)	(1.61)	(2.18)	(2.28)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

NRx Historical Financial Ratios

About NRx Financial Ratios Analysis

NRx Pharmaceuticals Financial Ratios Chart

Average Payables

Payables Turnover

NRx Pharmaceuticals fundamentals Correlations

NRx Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

NRx Pharmaceuticals fundamentals Accounts

Also Currently Popular

Additional Tools for NRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Cash Per Share	+ 1.0	Book Value Per Share
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Days Of Inventory On Hand	+ 1.0	Inventory Turnover
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio

Days Payables Outstanding	- 1.0	Inventory Turnover
Days Payables Outstanding	- 0.99	Days Of Inventory On Hand
Days Payables Outstanding	- 0.87	Cash Per Share
Pe Ratio	- 0.86	Income Quality
Days Payables Outstanding	- 0.86	Book Value Per Share
Days Payables Outstanding	- 0.84	Capex To Depreciation